Incannex Healthcare Inc. (IXHL) stock
IXHLNasdaqPharmaceutical PreparationsFiscal year ends June 30
$1.75+0.01 (+0.57%)
Close on Nov 18, 2026Market cap $21.95MP/E –Yield –
Incannex Healthcare operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Incannex Healthcare's operating income for the twelve months ending Sep 30, 2026 was -$19.67M. For fiscal 2026 it was -$23.03M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$23.03M | – |
| FY2025 | Jun 30, 2025 | -$23.79M | – |
| FY2024 | Jun 30, 2024 | -$30.04M | – |
| FY2023 | Jun 30, 2023 | -$49.67M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | -$3.44M | – |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | -$5.19M | – |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -$4.05M | – |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -$7.00M | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | -$6.79M | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -$7.53M | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | -$5.00M | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -$5.00M | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$6.25M | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$9.74M | – |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -$7.42M | – |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -$7.98M | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -$4.89M | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | -$4.19M | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -$3.65M | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -$3.64M | – |
See a number that looks wrong?